L-Arginine in coronary atherosclerosis

被引：24
|
作者：
Tentolouris, C
Tousoulis, D
Goumas, G
Stefanadis, C
Davies, G
Toutouzas, P
机构：
[1] Univ Athens, Sch Med, Hippokrat Hosp, Cardiol Unit, GR-11527 Athens, Greece
[2] Imperial Coll, Sch Med, Hammersmith Hosp, Cardiol Unit, London, England
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2000年 / 75卷 / 2-3期
关键词：
endothelium; nitric oxide; atherosclerosis; L-arginine;
D O I：
10.1016/S0167-5273(00)00320-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Nitric oxide is formed from the N-guanido terminal of the amino acid L-arginine and from molecular oxygen by nitric oxide synthase enzymes. L-arginine administration improves the coronary blood flow response to acetylcholine in patients with normal coronary arteries and hypercholesterolemia, reverses the defective endothelium-dependent vasodilation associated with an elevated plasma low-density lipoprotein level or hypercholesterolemia, dilates coronary epicardial arteries and stenoses, enhances nitric oxide generation, and inhibits lesion formation after balloon angioplasty. Stimulation of endogenous nitric oxide production could inhibit atherogenesis, and therefore may be of benefit in patients with risk factors for atherosclerosis. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：123 / 128
页数：6
相关论文
共 50 条
  • [21] THE EFFECT OF L-ARGININE ON BALANCING THE ENDOTHELIAL INJURY AND REPAIR IN EARLY ATHEROSCLEROSIS
    Javanmard, S. Haghjooy
    Nematbakhsh, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [22] L-ARGININE MAY INHIBIT ATHEROSCLEROSIS THROUGH INHIBITION OF LDL OXIDATION
    PHILISTSIMIKAS, A
    WITZTUM, JL
    CIRCULATION, 1995, 92 (08) : 2015 - 2015
  • [23] The L-arginine paradox:: Importance of the L-arginine/asymmetrical dimethylarginine ratio
    Bode-Boeger, Stefanie M.
    Scalera, Fortunato
    Ignarro, Louis J.
    PHARMACOLOGY & THERAPEUTICS, 2007, 114 (03) : 295 - 306
  • [24] Crystal structure and characterization of L-arginine chlorate and L-arginine bromate
    Petrosyan, AM
    Karapetyan, HA
    Sukiasyan, RP
    Aghajanyan, AE
    Morgunov, VG
    Kravchenko, EA
    Bush, AA
    JOURNAL OF MOLECULAR STRUCTURE, 2005, 752 (1-3) : 144 - 152
  • [25] L-arginine inhibits neutrophil adherence and coronary artery dysfunction
    Sato, H
    Zhao, ZQ
    VintenJohansen, J
    CARDIOVASCULAR RESEARCH, 1996, 31 (01) : 63 - 72
  • [26] L-arginine normalizes coronary vasomotion in chronic smokers.
    Campisi, R
    Czernin, J
    Schöder, H
    Sayre, JW
    Phelps, ME
    Schelbert, HR
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 3P - 3P
  • [27] L-arginine and thrombosis
    Tousoulis, D
    Tentolouris, C
    Toutouzas, P
    CIRCULATION, 2001, 104 (25) : E159 - E159
  • [28] Intravenous application of L-arginine in patients with acute coronary syndrome
    Kelm, M
    Trommer, I
    Rath, J
    Hetzel, G
    Grabensee, B
    Strauer, BE
    EUROPEAN HEART JOURNAL, 2003, 24 : 618 - 618
  • [29] Effects of dietary L-arginine on the reactivity of canine coronary arteries
    Ray, EC
    Landis, ME
    Miller, VM
    VASCULAR MEDICINE, 1999, 4 (04) : 211 - 217
  • [30] THE PERCARBOBENZOXYLATION OF L-ARGININE
    ZERVAS, L
    WINITZ, M
    GREENSTEIN, JP
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1956, 65 (02) : 573 - 574
12345